WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis
article
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study examined WT1 expression in endometrioid ovarian carcinoma, comparing cases with and without associated endometriosis to identify potential differences.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AimsTo determine how frequently endometrioid ovarian carcinomas (EOC) express WT1 protein, and to correlate the results with the presence of endometriosis and p53 immunoreactivity.MethodsForty-one grade 1-2 EOC were stained immunohistochemically for WT1 and p53 proteins. Twenty-one tumours were associated with endometriosis and 20 cases lacked such an association. WT1 expression in the tumour cell nuclei and/or cytoplasm was recorded. Nuclear p53 staining was assessed as diffuse (>50% cells positive), focal, or negative.ResultsFour of the 20 (20%) tumours in the endometriosis negative group showed nuclear WT1 staining, while none of the endometriosis-associated EOC was positive (p < 0.05). Two of the immunoreactive cases exhibited sertoliform/sex cord-like patterns. Focal cytoplasmic WT1 labelling was present in seven EOC, three of which showed sertoliform, spindle cell or corded and hyaline patterns. There was no correlation between WT1 expression and p53 immunoreactivity.ConclusionsNuclear WT1 expression is present in a minority of EOC and this should be considered if immunohistochemistry is used as an adjunct in sub-typing ovarian carcinomas. The negative correlation of WT1 staining with endometriosis supports the possibility that some EOC, including unusual histological variants, arise from the ovarian surface epithelium. Further studies of EOC should document any association with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (51)
- Precursor lesions of ovarian epithelial malignancy via openalex
- Recent Advances in Endometriosis With Emphasis on Pathogenesis, Molecular Pathology, and Neoplastic Transformation via openalex
- Role of Endometriosis in Cancer and Tumor Development via openalex
- W1969885904 via openalex
- W1976615153 via openalex
- W1976711975 via openalex
- W1979053455 via openalex
- W1979256213 via openalex
- W1983214093 via openalex
- W1983398046 via openalex
- W1984385354 via openalex
- W2000707699 via openalex
- W2004723089 via openalex
- W2011581825 via openalex
- W2012229186 via openalex
- W2021912560 via openalex
- W2022404774 via openalex
- W2023626813 via openalex
- W2027513095 via openalex
- W2028156591 via openalex
- W2029636223 via openalex
- W2030922808 via openalex
- W2042880757 via openalex
- W2044464259 via openalex
- W2044486013 via openalex
- W2046064533 via openalex
- W2050084756 via openalex
- W2053309322 via openalex
- W2065330227 via openalex
- W2066108428 via openalex
- W2073173960 via openalex
- W2079927757 via openalex
- W2080387155 via openalex
- W2086343491 via openalex
- W2095613768 via openalex
- W2099800942 via openalex
- W2113415002 via openalex
- W2119397070 via openalex
- W2122917555 via openalex
- W2123725304 via openalex
- W2126828680 via openalex
- W2157805037 via openalex
- W2168808424 via openalex
- W2168842414 via openalex
- W2415403230 via openalex
- W2474510365 via openalex
- W4229854891 via openalex
- W165620784 via openalex
- W4255462147 via openalex
- W1954448220 via openalex
- W1967646255 via openalex
Cited by (7)
- Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms—Review 2022
- Is there a relationship in-between ovarian endometriosis and ovarian cancer? Immunohistochemical profile of four cases with coexisting ovarian endometriosis and cancer 2020
- Endometriosis — insights into a multifaceted entity 2018
- Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: Correlation with KRAS mutation and the presence of endometriosis 2013
- KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis 2012
- Authors' Reply 2010
- Risk of carcinoma in women with ovarian endometrioma 2010
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:24.299271+00:00
- unpaywall
- last seen: 2026-07-26T06:48:27.953686+00:00
License: CC0
· commercial use OK